Your browser doesn't support javascript.
loading
Insulin upregulates betatrophin expression via PI3K/Akt pathway.
Lu, Puhan; Chen, Xi; Zhang, Zeqing; Zhang, Jianhua; Yang, Yan; Liu, Zhelong; Xie, Junhui; Shao, Shiying; Zhou, Xinrong; Hu, Shuhong; He, Wentao; Zhao, Jiajun; Yu, Xuefeng.
Afiliação
  • Lu P; Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
  • Chen X; Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
  • Zhang Z; Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
  • Zhang J; Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
  • Yang Y; Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
  • Liu Z; Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
  • Xie J; Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
  • Shao S; Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
  • Zhou X; Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
  • Hu S; Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
  • He W; Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
  • Zhao J; Department of Endocrinology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong Province, People's Republic of China.
  • Yu X; Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China. xfyu188@163.com.
Sci Rep ; 7(1): 5594, 2017 07 17.
Article em En | MEDLINE | ID: mdl-28717133

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Fosfatidilinositol 3-Quinases / Hormônios Peptídicos / Diabetes Mellitus Tipo 2 / Proteínas Proto-Oncogênicas c-akt / Proteínas Semelhantes a Angiopoietina / Insulina Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Fosfatidilinositol 3-Quinases / Hormônios Peptídicos / Diabetes Mellitus Tipo 2 / Proteínas Proto-Oncogênicas c-akt / Proteínas Semelhantes a Angiopoietina / Insulina Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article